Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin receptor substrate (IRS) proteins, primarily IRS-1 and IRS-2, are critical cytoplasmic adaptor molecules that mediate signaling downstream of the insulin receptor (IR) and insulin-like growth factor 1 receptor (IGF-1R). Upon ligand binding, the activated receptors phosphorylate IRS proteins on tyrosine residues, allowing them to recruit and activate key downstream effectors such as phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK) pathways. These cascades regulate essential cellular processes, including glucose homeostasis, lipid metabolism, cell growth, survival, and proliferation. Dysregulation of IRS signaling is heavily implicated in metabolic diseases like type 2 diabetes and obesity, where impaired IRS activation leads to insulin resistance. Additionally, constitutive activation or overexpression of IRS proteins is common in various cancers, promoting tumor growth, metastasis, and resistance to targeted therapies. Consequently, IRS has emerged as an attractive therapeutic target, with small-molecule inhibitors like NT157 and NT219 designed to induce IRS degradation, thereby blocking oncogenic signaling and overcoming drug resistance.
Allosteric inhibition, serine phosphorylation, and proteasomal degradation of IRS-1/2, or RNA interference-mediated knockdown of IRS-1
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin receptor substrate (IRS).